This announcement is a separate document:
鲁抗医药关于子公司药品通过仿制药一致性评价的公告
Lu Kang Pharmaceutical\'s announcement that its subsidiary drugs passed the generic drug consistency evaluation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.